Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
MED12 overexpression is a frequent event in castration-resistant prostate cancer.
Adler D, Offermann A, Braun M, Menon R, Syring I, Nowak M, Halbach R, Vogel W, Ruiz C, Zellweger T, Rentsch CA, Svensson M, Andren O, Bubendorf L, Biskup S, Duensing S, Kirfel J, Perner S. Adler D, et al. Among authors: kirfel j. Endocr Relat Cancer. 2014 Aug;21(4):663-675. doi: 10.1530/ERC-14-0171. Epub 2014 Jun 17. Endocr Relat Cancer. 2014. PMID: 24938407
Fibroblast growth factor receptor 1 amplification is a common event in squamous cell carcinoma of the head and neck.
Göke F, Bode M, Franzen A, Kirsten R, Goltz D, Göke A, Sharma R, Boehm D, Vogel W, Wagner P, Lengerke C, Kristiansen G, Kirfel J, Van Bremen T, Bootz F, Heasley LE, Schröck A, Perner S. Göke F, et al. Among authors: kirfel j. Mod Pathol. 2013 Oct;26(10):1298-306. doi: 10.1038/modpathol.2013.58. Epub 2013 Apr 26. Mod Pathol. 2013. PMID: 23619603 Free article.
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.
Adler D, Menon R, Braun M, Offermann A, Queisser A, Boehm D, Vogel W, Rüenauver K, Ruiz C, Zellweger T, Svensson M, Andren O, Kristiansen G, Wernert N, Bubendorf L, Kirfel J, Biskup S, Perner S. Adler D, et al. Among authors: kirfel j. Int J Cancer. 2014 Jul 1;135(1):19-26. doi: 10.1002/ijc.28647. Epub 2013 Dec 9. Int J Cancer. 2014. PMID: 24374838
Evaluation of FGFR3 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
von Mässenhausen A, Deng M, Billig H, Queisser A, Vogel W, Kristiansen G, Schröck A, Bootz F, Göke F, Franzen A, Heasley L, Kirfel J, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: kirfel j. Target Oncol. 2016 Oct;11(5):631-642. doi: 10.1007/s11523-016-0431-z. Target Oncol. 2016. PMID: 27053219
MERTK as a novel therapeutic target in head and neck cancer.
von Mässenhausen A, Sanders C, Thewes B, Deng M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Heasley L, Brägelmann J, Perner S. von Mässenhausen A, et al. Among authors: kirfel j. Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724. Oncotarget. 2016. PMID: 27081701 Free PMC article.
Targeting DDR2 in head and neck squamous cell carcinoma with dasatinib.
von Mässenhausen A, Sanders C, Brägelmann J, Konantz M, Queisser A, Vogel W, Kristiansen G, Duensing S, Schröck A, Bootz F, Brossart P, Kirfel J, Lengerke C, Perner S. von Mässenhausen A, et al. Among authors: kirfel j. Int J Cancer. 2016 Nov 15;139(10):2359-69. doi: 10.1002/ijc.30279. Epub 2016 Jul 30. Int J Cancer. 2016. PMID: 27434411
Ecotropic viral integration site 1, a novel oncogene in prostate cancer.
Queisser A, Hagedorn S, Wang H, Schaefer T, Konantz M, Alavi S, Deng M, Vogel W, von Mässenhausen A, Kristiansen G, Duensing S, Kirfel J, Lengerke C, Perner S. Queisser A, et al. Among authors: kirfel j. Oncogene. 2017 Mar;36(11):1573-1584. doi: 10.1038/onc.2016.325. Epub 2016 Sep 12. Oncogene. 2017. PMID: 27617580
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.
Brägelmann J, Klümper N, Offermann A, von Mässenhausen A, Böhm D, Deng M, Queisser A, Sanders C, Syring I, Merseburger AS, Vogel W, Sievers E, Vlasic I, Carlsson J, Andrén O, Brossart P, Duensing S, Svensson MA, Adler D, Kirfel J, Perner S. Brägelmann J, et al. Among authors: kirfel j. Clin Cancer Res. 2017 Apr 1;23(7):1829-1840. doi: 10.1158/1078-0432.CCR-16-0094. Epub 2016 Sep 27. Clin Cancer Res. 2017. PMID: 27678455
112 results